Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
Bayer Pharmaceuticals and Johnson & Johnson may soon face Xarelto class action lawsuits as more and more reports catalog a high number of patients allegedly suffering from uncontrollable bleeding after consuming the anticoagulant drug.
Xarelto is a “direct thrombin inhibitor,” a member of a new generation of anticoagulant drugs prescribed to reduce patients’ risk of strokes and blood clots. It is in the same class of drugs as Pradaxa, another anticoagulant prescription drug facing more than 4,000 lawsuits due to allegations of bleeding complications. The manufacturers of Pradaxa recently agreed to a $650 million settlement for Pradaxa victims.
There are only a handful of Xarelto lawsuits filed, but the number is expected to increase with the growing number of medical reports supporting the class action allegations.
One recent report published by a German newspaper said that Bayer executives recently acknowledged their awareness of the Xarelto product liability lawsuits filed in the U.S over the past year.
What is Xarelto?
Xarelto is an anticoagulant blood thinning medication prescribed to prevent strokes and blood clots in patients suffering from atrial fibrillation after undergoing hip and knee replacement surgery. The drug was jointly developed by Bayer Pharmaceutical and Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, and was introduced into the American drug market in 2011.
J&J and Bayer marketed the product as a superior blood thinner alternative to the popular, standard Coumadin (otherwise known as Warfarin) drug prescribed for anticoagulant therapy. However, many consumers and physicians have reported unwanted and often dangerous Xarelto side effects allegedly caused by using the drug.
Xarelto side effects include:
- Deep vein thrombosis
- Pulmonary embolism
- Abdominal bleeding
- Gastrointestinal bleeding
- Brain hemorrhaging
- Abnormal liver function
- Reduced platelet levels
- Dizziness
- Hemorrhaging in the eyes
- Low blood pressure
- Nose bleeds
- Rectal bleeding
- Headache
- Muscle pain
- Rapid heartbeat
- Bruising
- Edema
The 10 Xarelto lawsuits currently in litigation make similar claims alleging that Bayer and J&J withheld important information from Xarelto consumers and did not inform the medical community of the absence of an effective reversal agent to combat the uncontrollable bleeding reported with Xarelto use.
Join a Free Xarelto Class Action Lawsuit Investigation
If you or a loved one took Xarelto (rivaroxaban) and suffered injuries such as uncontrollable internal bleeding, gastrointestinal bleeding, hemorrhaging, deep vein thrombosis or pulmonary embolism, you may have a legal claim. See if you qualify to join a free Xarelto class action lawsuit investigation and pursue compensation for you or your loved one’s injuries:
Oops! We could not locate your form.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
The family of a Utah woman who allegedly died in 2012 from Xarelto bleeding problems is suing Janssen Pharmaceuticals, a sister company of Bayer Corp, for failing to warn about the risk of life-threatening Xarelto side effects. They are seeking over $75,000 in damages for her death, which they claim was caused by the blood thinning medication.
Xarelto has been the subject of numerous personal injury lawsuits alleging the drug can cause unstoppable internal bleeding, particularly brain bleeds.
According to the latest Xarelto lawsuit, the decedent Margaret Armstrong began taking Xarelto in February 2012 to reduce her risk of stroke and pulmonary embolism after being diagnosed with atrial fibrillation.
Armstrong allegedly read the package labeling of Xarelto, which had no warning about the risk of life-threatening, irreversible bleeding from the use of Xarelto. Armstrong continued to use Xarelto until August 2012, when disaster struck.
On Aug. 26, 2012, Armstrong was taken to the nearest Utah hospital to be treated for what ultimately was a subdural hematoma, or a collection of blood on the surface of the brain. She was unable to recover and suffered an untimely death just days later on Aug. 30, according to the Xarelto lawsuit.
It is alleged in the Xarelto lawsuit that had Armstrong known about the risk of dangerous and irreversible internal bleeding from Xarelto use, she would have never agreed to be prescribed the drug. In addition, it is alleged that her physician was not properly warned about the high risk of internal bleeding as a result of Xarelto.
Xarelto Bleeding Reports Grow
Xarelto was approved by the Food and Drug Administration (FDA) in July 2011 for the prevention of DVT (deep vein thrombosis) and PE (pulmonary embolism) in patients that have undergone hip replacement surgery.
In November 2011, Xarelto was further approved for patients to reduce their risk of stroke and/or systemic embolism. However, this blood thinning benefit of Xarelto was not made explicit on their labeling until November 2012.
By June 2012, there were over 1,080 serious adverse event reports reported by consumers to the FDA, all involving Xarelto bleeding problems. Of those 1,080 event reports, 65 were deaths. By the end of 2012, there were over 2,000 serious adverse event reports sent to the FDA by consumers that had taken Xarelto — 151 of those cases resulted in death.
In addition, German regulators reportedly received 968 adverse event reports from consumers regarding Xarelto that same year, with 72 of those being deaths.
Dozens of Xarelto bleeding lawsuits have since been filed. Plaintiffs are seeking compensation from Janssen for failure to warn and negligent marketing, manufacture and sale of a product linked to serious injury.
In general, Xarelto lawsuits are filed individually by each plaintiff and are not class actions.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or class action lawsuit is best for you. Hurry — statutes of limitations may apply.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Xarelto Class Action Lawsuit Investigation
If you or a loved one took Xarelto (rivaroxaban) and suffered injuries such as uncontrollable internal bleeding, gastrointestinal bleeding, hemorrhaging, deep vein thrombosis or pulmonary embolism, you may have a legal claim. See if you qualify by filling out the short form below.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
Oops! We could not locate your form.
